[EN] NOVEL REFERENCE MARKERS OF DABIGATRAN ETEXILATE<br/>[FR] NOUVEAUX MARQUEURS DE RÉFÉRENCE D'ÉTÉXILATE DE DABIGATRAN
申请人:ALEMBIC PHARMACEUTICALS LTD
公开号:WO2013024394A1
公开(公告)日:2013-02-21
A new method of obtaining chemically pure and pharmaceutically acceptable Dabigatran Etexilate or its pharmaceutical acceptable salt having purity at least about 99% is provided, wherein the content of Dabigatran Etexilate individual impurity is less than 0.03-0.15% as measured by HPLC. A method of removing specific impurities that are generated either due to the intrinsic instability of Dabigatran Etexilate or in process of its preparation is provided too.
提供了一种获得化学纯和药学可接受的达比加群胺乙酯或其药学可接受的盐的新方法,其纯度至少为约99%,其中达比加群胺乙酯个体杂质的含量小于0.03-0.15%,通过HPLC测量。还提供了一种去除特定杂质的方法,这些杂质是由达比加群胺乙酯的固有不稳定性或制备过程中产生的。